| Mr Marcus K Richeson, DC | |
|
15043 Main St, Alachua, FL 32615-3637 | |
| (386) 462-5886 | |
| (386) 462-4668 |
| Full Name | Mr Marcus K Richeson |
|---|---|
| Gender | Male |
| Speciality | Chiropractic |
| Experience | 24 Years |
| Location | 15043 Main St, Alachua, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1417922378 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 111N00000X | Chiropractor | CM8258 (Florida) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Chiropractic Associates Of Alachua Pa | 2860597887 | 2 |
News Archive
Almost half of patients with non-metastatic renal cell carcinoma who have tumour thrombus above the hepatic veins will survive for 5 years after surgery, indicate study results published in The Journal of Urology.
Researchers at the University of California, San Diego School of Medicine have identified a link between patients who undergo total nephrectomy - complete kidney removal - and erectile dysfunction.
Intellect Neurosciences, Inc., a biopharmaceutical company focused on development of disease-modifying therapeutic agents for Alzheimer's disease, announced today it has completed a restructuring of its balance sheet. The result is the extinguishment of approximately $24 million of aggregate face amount plus accrued interest of debt and preferred stock through the issuance of common stock.
ARIAD Pharmaceuticals, Inc. today announced it has completed the rolling submission of the New Drug Application (NDA) for its investigational BCR-ABL inhibitor, ponatinib, to the U.S. Food and Drug Administration (FDA).
› Verified 5 days ago
| Provider Name | Chiropractic Associates Of Alachua Pa |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1548324239 PECOS PAC ID: 2860597887 Enrollment ID: O20070420000098 |
News Archive
Almost half of patients with non-metastatic renal cell carcinoma who have tumour thrombus above the hepatic veins will survive for 5 years after surgery, indicate study results published in The Journal of Urology.
Researchers at the University of California, San Diego School of Medicine have identified a link between patients who undergo total nephrectomy - complete kidney removal - and erectile dysfunction.
Intellect Neurosciences, Inc., a biopharmaceutical company focused on development of disease-modifying therapeutic agents for Alzheimer's disease, announced today it has completed a restructuring of its balance sheet. The result is the extinguishment of approximately $24 million of aggregate face amount plus accrued interest of debt and preferred stock through the issuance of common stock.
ARIAD Pharmaceuticals, Inc. today announced it has completed the rolling submission of the New Drug Application (NDA) for its investigational BCR-ABL inhibitor, ponatinib, to the U.S. Food and Drug Administration (FDA).
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Marcus K Richeson, DC 15043 Main St, Alachua, FL 32615-3637 Ph: (386) 462-5886 | Mr Marcus K Richeson, DC 15043 Main St, Alachua, FL 32615-3637 Ph: (386) 462-5886 |
News Archive
Almost half of patients with non-metastatic renal cell carcinoma who have tumour thrombus above the hepatic veins will survive for 5 years after surgery, indicate study results published in The Journal of Urology.
Researchers at the University of California, San Diego School of Medicine have identified a link between patients who undergo total nephrectomy - complete kidney removal - and erectile dysfunction.
Intellect Neurosciences, Inc., a biopharmaceutical company focused on development of disease-modifying therapeutic agents for Alzheimer's disease, announced today it has completed a restructuring of its balance sheet. The result is the extinguishment of approximately $24 million of aggregate face amount plus accrued interest of debt and preferred stock through the issuance of common stock.
ARIAD Pharmaceuticals, Inc. today announced it has completed the rolling submission of the New Drug Application (NDA) for its investigational BCR-ABL inhibitor, ponatinib, to the U.S. Food and Drug Administration (FDA).
› Verified 5 days ago
Dr. Jason T Powell, DC Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 15043 Main St, Alachua, FL 32615 Phone: 386-462-5886 Fax: 386-462-4668 | |
Dr. Alexandrea Danielle Williams, DC Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 15202 Nw 147th Dr Ste 1500, Alachua, FL 32615 Phone: 352-359-3192 | |
Chiropractic Associates Of Alachua, P.a. Chiropractor Medicare: Medicare Enrolled Practice Location: 15043 Main St., Alachua, FL 32615 Phone: 386-462-5886 | |
Dna Chiropractic And Performance Llc Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 15202 Nw 147th Dr Ste 1500, Alachua, FL 32615 Phone: 352-359-3192 |